Implementing shared decision making for early-stage breast cancer treatment using a coproduction learning collaborative: the SHAIR Collaborative protocol.
Journal
Implementation science communications
ISSN: 2662-2211
Titre abrégé: Implement Sci Commun
Pays: England
ID NLM: 101764360
Informations de publication
Date de publication:
14 Jul 2023
14 Jul 2023
Historique:
received:
12
04
2023
accepted:
04
06
2023
medline:
15
7
2023
pubmed:
15
7
2023
entrez:
14
7
2023
Statut:
epublish
Résumé
Shared decision making (SDM) in breast cancer care improves outcomes, but it is not routinely implemented. Results from the What Matters Most trial demonstrated that early-stage breast cancer surgery conversation aids, when used by surgeons after brief training, improved SDM and patient-reported outcomes. Trial surgeons and patients both encouraged using the conversation aids in routine care. We will develop and evaluate an online learning collaborative, called the SHared decision making Adoption Implementation Resource (SHAIR) Collaborative, to promote early-stage breast cancer surgery SDM by implementing the conversation aids into routine preoperative care. Learning collaboratives are known to be effective for quality improvement in clinical care, but no breast cancer learning collaborative currently exists. Our specific aims are to (1) provide the SHAIR Collaborative resources to clinical sites to use with eligible patients, (2) examine the relationship between the use of the SHAIR Collaborative resources and patient reach, and (3) promote the emergence of a sustained learning collaborative in this clinical field, building on a partnership with the American Society of Breast Surgeons (ASBrS). We will conduct a two-phased implementation project: phase 1 pilot at five sites and phase 2 scale up at up to an additional 32 clinical sites across North America. The SHAIR Collaborative online platform will offer free access to conversation aids, training videos, electronic health record and patient portal integration guidance, a feedback dashboard, webinars, support center, and forum. We will use RE-AIM for data collection and evaluation. Our primary outcome is patient reach. Secondary data will include (1) patient-reported data from an optional, anonymous online survey, (2) number of active sites and interviews with site champions, (3) Normalization MeAsure Development questionnaire data from phase 1 sites, adaptations data utilizing the Framework for Reporting Adaptations and Modifications-Extended/-Implementation Strategies, and tracking implementation facilitating factors, and (4) progress on sustainability strategy and plans with ASBrS. The SHAIR Collaborative will reach early-stage breast cancer patients across North America, evaluate patient-reported outcomes, engage up to 37 active sites, and potentially inform engagement factors affecting implementation success and may be sustained by ASBrS.
Sections du résumé
BACKGROUND
BACKGROUND
Shared decision making (SDM) in breast cancer care improves outcomes, but it is not routinely implemented. Results from the What Matters Most trial demonstrated that early-stage breast cancer surgery conversation aids, when used by surgeons after brief training, improved SDM and patient-reported outcomes. Trial surgeons and patients both encouraged using the conversation aids in routine care. We will develop and evaluate an online learning collaborative, called the SHared decision making Adoption Implementation Resource (SHAIR) Collaborative, to promote early-stage breast cancer surgery SDM by implementing the conversation aids into routine preoperative care. Learning collaboratives are known to be effective for quality improvement in clinical care, but no breast cancer learning collaborative currently exists. Our specific aims are to (1) provide the SHAIR Collaborative resources to clinical sites to use with eligible patients, (2) examine the relationship between the use of the SHAIR Collaborative resources and patient reach, and (3) promote the emergence of a sustained learning collaborative in this clinical field, building on a partnership with the American Society of Breast Surgeons (ASBrS).
METHODS
METHODS
We will conduct a two-phased implementation project: phase 1 pilot at five sites and phase 2 scale up at up to an additional 32 clinical sites across North America. The SHAIR Collaborative online platform will offer free access to conversation aids, training videos, electronic health record and patient portal integration guidance, a feedback dashboard, webinars, support center, and forum. We will use RE-AIM for data collection and evaluation. Our primary outcome is patient reach. Secondary data will include (1) patient-reported data from an optional, anonymous online survey, (2) number of active sites and interviews with site champions, (3) Normalization MeAsure Development questionnaire data from phase 1 sites, adaptations data utilizing the Framework for Reporting Adaptations and Modifications-Extended/-Implementation Strategies, and tracking implementation facilitating factors, and (4) progress on sustainability strategy and plans with ASBrS.
DISCUSSION
CONCLUSIONS
The SHAIR Collaborative will reach early-stage breast cancer patients across North America, evaluate patient-reported outcomes, engage up to 37 active sites, and potentially inform engagement factors affecting implementation success and may be sustained by ASBrS.
Identifiants
pubmed: 37452387
doi: 10.1186/s43058-023-00453-z
pii: 10.1186/s43058-023-00453-z
pmc: PMC10349513
doi:
Types de publication
Journal Article
Langues
eng
Pagination
79Subventions
Organisme : NCI NIH HHS
ID : P30 CA023108
Pays : United States
Organisme : Patient-Centered Outcomes Research Institute
ID : SDM-2020C2-20307
Pays : United States
Informations de copyright
© 2023. The Author(s).
Références
JMIR Cancer. 2018 Nov 21;4(2):e11102
pubmed: 30463840
Cancer. 2008 Mar 1;112(5):1153-61
pubmed: 18189306
J Am Coll Surg. 2012 Jan;214(1):1-10
pubmed: 22056355
J Med Internet Res. 2014 Jan 03;16(1):e2
pubmed: 24389354
BMC Med Inform Decis Mak. 2013;13 Suppl 2:S14
pubmed: 24625083
Stat Med. 2013 Feb 20;32(4):539-55
pubmed: 23023735
Qual Manag Health Care. 2005 Oct-Dec;14(4):234-47
pubmed: 16227872
Implement Sci. 2019 Sep 2;14(1):88
pubmed: 31477140
Patient Educ Couns. 2006 Dec;64(1-3):303-12
pubmed: 16860523
J Bone Joint Surg Am. 2019 Sep 18;101(18):1645-1653
pubmed: 31567801
Int J Environ Res Public Health. 2021 Feb 22;18(4):
pubmed: 33671649
Med Decis Making. 2014 Jan;34(1):54-62
pubmed: 23776141
J Gen Intern Med. 2014 Jan;29(1):219-22
pubmed: 24002635
Patient Educ Couns. 2020 Nov;103(11):2235-2243
pubmed: 32782181
BMJ. 2017 Nov 6;359:j4891
pubmed: 29109079
PLoS One. 2012;7(5):e36250
pubmed: 22615760
Patient Educ Couns. 2016 Apr;99(4):571-577
pubmed: 26566194
Implement Sci. 2021 May 10;16(1):51
pubmed: 33971913
Int J Integr Care. 2015 Mar 27;15:e008
pubmed: 26034467
Implement Sci. 2021 Apr 7;16(1):36
pubmed: 33827716
J Clin Oncol. 2002 Mar 15;20(6):1473-9
pubmed: 11896094
BMC Med Inform Decis Mak. 2012 Jun 08;12:51
pubmed: 22681763
Health Promot Pract. 2006 Jul;7(3):312-23
pubmed: 16760238
Implement Sci. 2019 Jun 6;14(1):58
pubmed: 31171014
BMJ Qual Saf. 2016 Jul;25(7):509-17
pubmed: 26376674
J Clin Oncol. 2009 Feb 1;27(4):519-25
pubmed: 19114703
J Patient Exp. 2021 Apr 13;8:23743735211007346
pubmed: 34179413
Z Evid Fortbild Qual Gesundhwes. 2018 Jul;134:1-8
pubmed: 29858145
Patient Educ Couns. 2019 May;102(5):817-841
pubmed: 30612829
BMJ. 2017 Mar 6;356:i6795
pubmed: 28264797
PLoS One. 2015 Jun 25;10(6):e0131712
pubmed: 26110842
Cancer. 2021 Feb 1;127(3):422-436
pubmed: 33170506
JAMA. 1997 May 14;277(18):1485-92
pubmed: 9145723
Milbank Q. 2004;82(4):581-629
pubmed: 15595944
Clin Breast Cancer. 2023 Jan;23(1):e20-e31
pubmed: 36357267
BMJ. 2018 Nov 28;363:k4738
pubmed: 30487232
Patient Educ Couns. 2013 Oct;93(1):102-7
pubmed: 23768763
Patient Educ Couns. 2007 Mar;65(3):387-95
pubmed: 17156967
Front Public Health. 2019 Mar 29;7:64
pubmed: 30984733
BMC Health Serv Res. 2007 Sep 19;7:148
pubmed: 17880693
BMJ Qual Saf. 2018 Mar;27(3):226-240
pubmed: 29055899
Annu Rev Public Health. 1998;19:173-202
pubmed: 9611617
JAMA. 2020 Jun 16;323(23):2375-2376
pubmed: 32421170
BMC Med Res Methodol. 2018 Nov 15;18(1):133
pubmed: 30442093
J Med Internet Res. 2021 May 3;23(5):e22766
pubmed: 33938806